EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry

Franklin Ducatez, Wladimir Mauhin, Jules Ottaviani, Thomas Plichet, Carine Pilon, Olivier Lidove, Fréderic Barbey, Régine Perrichot, Sabrina Vergnaud, Marc G Berger, Juliette Berger, Nadia Belmatoug und 6 weitere

Journal of Clinical Laboratory Analysis · 2025

DOI: 10.1002/jcla.25131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Franklin Ducatez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Biochemistry, Referral Center for Lysosomal Diseases, Normandie Univ, UNIROUEN, AIMS, SysMedLab, CHU Rouen, Rouen, France. Hauptthemen laut MEDLINE: Dried Blood Spot Testing, Sphingolipids, Mass Spectrometry, Sphingolipidoses. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sphingolipidoses are rare inherited metabolic diseases belonging to lysosomal diseases. Early and accurate diagnosis is crucial for effective management and treatment. In this study, we aimed to develop a robust method to accelerate the diagnosis of these sphingolipidoses using dried blood spots and plasma.

Method

We employed high‐resolution mass spectrometry coupled with liquid chromatography (LC‐HRMS) to analyze 6 lysosphingolipids (GlcSph/Psychosine, LysoGb3, LysoSM, LysoSM509, LysoGM1, and LysoGM2) on dried blood spots and plasma samples. The method was used to measure the lysosphingolipid levels in a group of 30 control subjects and 204 samples from patients with sphingolipidoses (61 dB and 143 plasma) including Fabry, Gaucher, GM2 Gangliodosis, Niemann‐Pick type A/B, and Niemann‐Pick type C.

Results

The developed multiplex LC‐HRMS method demonstrated linearity, precision, and quantification performances particularly for GlcSph/Psychosine and LysoGb3 on samples including controls and patients with sphingolipidoses. LysoSM showed recovery variability, wherease LysoGM1 and LysoGM2 showed higher matrix effect.

Conclusion

Our study presents a high‐resolution mass spectrometry method along with the established cutoff values, providing a valuable tool for targeted screening, accurate diagnosis, and monitoring sphingolipidoses. Furthermore, DBS showed reliable results that lay the path to a broader adoption for screening these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dried Blood Spot TestingSphingolipidsMass SpectrometrySphingolipidosesHumansChromatography, LiquidMaleFemaleReproducibility of ResultsCase-Control StudiesAdult

Stichwörter der Autor:innen

dried blood spotlysosomal diseasesmass spectrometryscreeningsphingolipids

Substanzen

Sphingolipids

Autor:innen und Institutionen

  • Department of Metabolic Biochemistry, Referral Center for Lysosomal Diseases, Normandie Univ, UNIROUEN, AIMS, SysMedLab, CHU Rouen, Rouen, France.
  • Department of Neonatal Pediatrics, Intensive Care, and Neuropediatrics, Referral Center for Lysosomal Diseases, Normandie Univ, UNIROUEN, INSERM U1245, CHU Rouen, Rouen, France.
  • Department of Internal Medicine-Rheumatology, Referral Center for Lysosomal Diseases, filière G2M, GH Diaconesses, Croix Saint Simon Hospital, Paris, France.
  • Department of Immunology, University of Lausanne and University Hospital of Lausanne, Switzerland.
  • Service de Néphrologie, Centre Hospitalier de Bretagne Atlantique, Vannes, France.
  • UF Maladies Héréditaires Enzymatiques Rares-CGD, Institut de Biologie et de Pathologies, CHU de Grenoble Alpes, Grenoble, France.

ORCID-Profile: Abdellah Tebani

Zitieren

APA

Ducatez, F., Mauhin, W., Ottaviani, J., Plichet, T., Pilon, C., Lidove, O., Barbey, F., Perrichot, R., Vergnaud, S., Berger, M. G., Berger, J., Belmatoug, N., Nadjar, Y., Lamari, F., Noel, E., Marret, S., Bekri, S., & Tebani, A. (2025). Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.25131

Vancouver

Ducatez F, Mauhin W, Ottaviani J, Plichet T, Pilon C, Lidove O, et al. Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.25131

BibTeX
@article{Ducatez2025,
  author = {Ducatez, Franklin and Mauhin, Wladimir and Ottaviani, Jules and Plichet, Thomas and Pilon, Carine and Lidove, Olivier and Barbey, Fréderic and Perrichot, Régine and Vergnaud, Sabrina and Berger, Marc G and Berger, Juliette and Belmatoug, Nadia and Nadjar, Yann and Lamari, Foudil and Noel, Esther and Marret, Stéphane and Bekri, Soumeya and Tebani, Abdellah},
  title = {Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2025},
  doi = {10.1002/jcla.25131}
}
Kostenlos starten →